Seems like it could be good news. But don't clinical studies of minoxidil show "statistically significant" regrowth too (and I don't think of minoxidil as a legitimate treatment, let alone a cure)?
"Patients who took the drug seemed to see the number of hairs in a one square centimeter area of their scalp increase, while those in the control group lost hair. In the control group, hair count dropped from 114 hairs per square centimeter to 111.5. In the 0.15% group, hair count increased from 104.9 to 115. In the 0.25% group, hair count increased from 110.8 to 118.5."
Keep in mind, the results are just from 90 days of use, and hair counts were performed at baseline, on day 90 and day 135. There was continued improvement even 45 days after the treatment was stopped.
03-07-2017 03:16 PM
FearTheLoss
Anyone know what their next step is? If they are planning to head into phase three next or what?
"
- SM04554 may be the first treatment leading to follicular neogenesis
- Both treatment groups exhibited statistically significantly higher total follicle counts compared to vehicle
"
It's notable because if I'm not mistaken, Histogen's Gail Naughton talks in one of her interviews about it being augmented a lot by something that could cause new follicles to start forming. I think Follica was suggested at the time. But this could be useful.
"
- SM04554 may be the first treatment leading to follicular neogenesis
- Both treatment groups exhibited statistically significantly higher total follicle counts compared to vehicle
"
03-26-2017 11:15 AM
BoSox
Quote:
Originally Posted by Gon
for this
Ohhh, they even saw growth when the treatment was stopped. I hope this doesn't just grow "some of our lost hair". Anybody know when they plan on commercializing this?
03-26-2017 11:16 AM
BoSox
Quote:
Originally Posted by Gon
for this
Ohhh, they even saw growth when the treatment was stopped. I hope this doesn't just grow "some of our lost hair". Anybody know when they plan on commercializing this?
SORRY FOR THE DOUBLE POSTS. MY INTERNET KEEPS LAGGING.